Ameriprise’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48M Buy
52,697
+40,249
+323% +$3.24M ﹤0.01% 2621
2026
Q1
$939K Buy
12,448
+2,330
+23% +$171K ﹤0.01% 3323
2025
Q4
$687K Sell
10,118
-114
-1% -$7.12K ﹤0.01% 3505
2025
Q3
$584K Buy
+10,232
New +$606K ﹤0.01% 3581
2023
Q4
Sell
-102,499
Closed -$1.94M 3912
2023
Q3
$1.94M Buy
+102,499
New +$1.95M ﹤0.01% 2829

Other funds holding DBD

Ameriprise's DBD Position: Q2 2026 in Review

Ameriprise increased its Diebold Nixdorf (DBD) stake by 323% in Q2 2026, buying an estimated $3.24M and bringing the position to 52,697 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2621.

Ameriprise first reported a position in DBD in Q3 2023 and has held it in 5 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Ameriprise held 52,697 shares of Diebold Nixdorf worth $4.48M as of Q2 2026.
  • Ameriprise bought 40,249 Diebold Nixdorf shares in Q2 2026, an estimated $3.24M.
  • Diebold Nixdorf made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2621 holding.
  • Ameriprise first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 5 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.